Related references
Note: Only part of the references are listed.Fluconazole-Induced adrenal insufficiency following allogeneic hematopoietic cell transplant
Craig W. Freyer et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2022)
Late endocrine effects after hematopoietic stem cell transplantation in children with nonmalignant diseases
L. C. de Kloet et al.
BONE MARROW TRANSPLANTATION (2022)
New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays
Bradley R. Javorsky et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation
Pinar Ataca Atilla et al.
CLINICAL TRANSPLANTATION (2020)
Prevalence of Secondary Adrenal Insufficiency in Recipients of Pediatric Hematopoietic Stem Cell Transplant: A Single Center Study
Emily Gray et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: an Italian cohort study
V. Mandese et al.
BMC PEDIATRICS (2019)
Late effects after hematopoietic stem cell transplantation for beta-thalassemia major: the French national experience
Ilhem Rahal et al.
HAEMATOLOGICA (2018)
Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features
Nadia Pariani et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Late effects after hematopoietic stem cell transplantation for beta-thalassemia major: the French national experience
Ilhem Rahal et al.
HAEMATOLOGICA (2018)
Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation
Eliane Gluckman et al.
BLOOD (2017)
Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
Michael Medinger et al.
LEUKEMIA RESEARCH (2017)
Poor growth, thyroid dysfunction and vitamin D deficiency remain prevalent despite reduced intensity chemotherapy for hematopoietic stem cell transplantation in children and young adults
K. C. Myers et al.
BONE MARROW TRANSPLANTATION (2016)
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy
Orla Tuohy et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Autoimmune Thyroid Disease Following Alemtuzumab Therapy and Hematopoietic Cell Transplantation in Pediatric Patients With Sickle Cell Disease
Kristen M. Williams et al.
PEDIATRIC BLOOD & CANCER (2014)
Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells
Francesco Orio et al.
SCIENTIFIC WORLD JOURNAL (2014)
G95 Endocrine Late-Effects Post-Haematopoietic Stem Cell Transplant(HSCT) in Children with Haemoglobinopathies
Y. Baki et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2013)
Thyroid dysfunction in thalassaemic patients: ferritin as a prognostic marker and combined iron chelators as an ideal therapy
Valeria Chirico et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
High Prevalence of Adrenal Insufficiency in Patients with Sickle Cell Disease: Results from a Community Hospital in the U.S.
J. Makino et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2013)
Frequency and Risk Factors of Endocrine Complications in Turkish Children and Adolescents with Sickle Cell Anemia
Samim Ozen et al.
TURKISH JOURNAL OF HEMATOLOGY (2013)
Secondary autoimmune diseases following alemtuzumab therapy for multiple sclerosis
Lisa Costelloe et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort
M. Cossburn et al.
NEUROLOGY (2011)
Chronic pain therapy and hypothalamic-pituitary-adrenal axis impairment
Anna Maria Aloisi et al.
PSYCHONEUROENDOCRINOLOGY (2011)
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
Ersi Voskaridou et al.
BLOOD (2010)
Prolonged Chronic Graft-versus-Host Disease is a Risk Factor for Thyroid Failure in Long-Term Survivors After Matched Sibling Donor Stem Cell Transplantation for Hematologic Malignancies
Bipin N. Savani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Thyroid function following hematopoietic cell transplantation in children: 30 years' experience
Jean E. Sanders et al.
BLOOD (2009)
Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease
Ellen B. Fung et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Oxidative stress and inflammation in iron-overloaded patients with β-thalassaemia or sickle cell disease
Patrick B. Walter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Thyroid dysfunction in adult long-term survivors after hemapoeitic stem-cell transplantation (HSCT)
M Somali et al.
HORMONE AND METABOLIC RESEARCH (2005)
Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation
WY Au et al.
BONE MARROW TRANSPLANTATION (2005)
Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning
MA Slatter et al.
BONE MARROW TRANSPLANTATION (2004)
Endocrine late effects after bone marrow transplant
BMD Brennan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Changes in autoimmune thyroid disease following allogeneic bone marrow transplantation
WY Lee et al.
BONE MARROW TRANSPLANTATION (2001)
Share Paper
